CMPX vs META · $367.4M cap vs P/E 29, rev $200.97B
Compass Therapeutics Inc. (CMPX) versus Meta Platforms Inc. (META) — a side-by-side from cached financials, not a winner call.
Compass Therapeutics Inc. (CMPX) is a biotechnology company listed on US.
Meta Platforms Inc. (META) is a internet content & information company listed on US. It is led by Mark Zuckerberg.
CMPX does not have a complete income-statement cache yet.
Latest reported META revenue for 2025-12-31 was $200.97B. Net income was $60.46B. Revenue was up 22.2% from 2024-12-31 to 2025-12-31. META currently screens at market cap $1.64T and trailing P/E 28.8.
CMPX currently screens at market cap $367.4M. META currently screens at market cap $1.64T and trailing P/E 28.8.
Not investment advice. Open the CMPX and META stock pages for the full models.
Not investment advice.